Hypericum perforatum
Related entities
Findings (27)
None
improvementIn the pooled hypericum arms (n=147), early improvement in somatic-gastrointestinal (p<0.001, r2=0.262) and hypochondriasis (p=0.004, r2=0.218) items from baseline to week 1 significantly predicted re
Effect: improvement; somatic-GI: p<0.001, r2=0.262; hypochondriasis: p=0.004, r2=0.218
None
improvementIn the pooled hypericum arms (n=147), early improvement in somatic-gastrointestinal (p<0.001, r2=0.262) and hypochondriasis (p=0.004, r2=0.218) items from baseline to week 1 significantly predicted re
Effect: improvement; somatic-GI: p<0.001, r2=0.262; hypochondriasis: p=0.004, r2=0.218
None
improvementIn the pooled hypericum arms (n=147), early improvement in somatic-gastrointestinal (p<0.001, r2=0.262) and hypochondriasis (p=0.004, r2=0.218) items from baseline to week 1 significantly predicted re
Effect: improvement; somatic-GI: p<0.001, r2=0.262; hypochondriasis: p=0.004, r2=0.218
None
improvementIn the pooled hypericum arms (n=147), early improvement in somatic-gastrointestinal (p<0.001, r2=0.262) and hypochondriasis (p=0.004, r2=0.218) items from baseline to week 1 significantly predicted re
Effect: improvement; somatic-GI: p<0.001, r2=0.262; hypochondriasis: p=0.004, r2=0.218
None
improvementIn the pooled hypericum arms (n=147), early improvement in somatic-gastrointestinal (p<0.001, r2=0.262) and hypochondriasis (p=0.004, r2=0.218) items from baseline to week 1 significantly predicted re
Effect: improvement; somatic-GI: p<0.001, r2=0.262; hypochondriasis: p=0.004, r2=0.218
None
improvementIn the pooled hypericum arms (n=147), early improvement in somatic-gastrointestinal (p<0.001, r2=0.262) and hypochondriasis (p=0.004, r2=0.218) items from baseline to week 1 significantly predicted re
Effect: improvement; somatic-GI: p<0.001, r2=0.262; hypochondriasis: p=0.004, r2=0.218
None
improvementIn the pooled hypericum arms (n=147), early improvement in somatic-gastrointestinal (p<0.001, r2=0.262) and hypochondriasis (p=0.004, r2=0.218) items from baseline to week 1 significantly predicted re
Effect: improvement; somatic-GI: p<0.001, r2=0.262; hypochondriasis: p=0.004, r2=0.218
None
improvementIn the pooled hypericum arms (n=147), early improvement in somatic-gastrointestinal (p<0.001, r2=0.262) and hypochondriasis (p=0.004, r2=0.218) items from baseline to week 1 significantly predicted re
Effect: improvement; somatic-GI: p<0.001, r2=0.262; hypochondriasis: p=0.004, r2=0.218
None
improvementIn the pooled hypericum arms (n=147), early improvement in somatic-gastrointestinal (p<0.001, r2=0.262) and hypochondriasis (p=0.004, r2=0.218) items from baseline to week 1 significantly predicted re
Effect: improvement; somatic-GI: p<0.001, r2=0.262; hypochondriasis: p=0.004, r2=0.218
None
improvementIn the pooled hypericum arms (n=147), early improvement in somatic-gastrointestinal (p<0.001, r2=0.262) and hypochondriasis (p=0.004, r2=0.218) items from baseline to week 1 significantly predicted re
Effect: improvement; somatic-GI: p<0.001, r2=0.262; hypochondriasis: p=0.004, r2=0.218
None
improvementIn the pooled hypericum arms (n=147), early improvement in somatic-gastrointestinal (p<0.001, r2=0.262) and hypochondriasis (p=0.004, r2=0.218) items from baseline to week 1 significantly predicted re
Effect: improvement; somatic-GI: p<0.001, r2=0.262; hypochondriasis: p=0.004, r2=0.218
None
improvementIn the pooled hypericum arms (n=147), early improvement in somatic-gastrointestinal (p<0.001, r2=0.262) and hypochondriasis (p=0.004, r2=0.218) items from baseline to week 1 significantly predicted re
Effect: improvement; somatic-GI: p<0.001, r2=0.262; hypochondriasis: p=0.004, r2=0.218
None
improvementIn the pooled hypericum arms (n=147), early improvement in somatic-gastrointestinal (p<0.001, r2=0.262) and hypochondriasis (p=0.004, r2=0.218) items from baseline to week 1 significantly predicted re
Effect: improvement; somatic-GI: p<0.001, r2=0.262; hypochondriasis: p=0.004, r2=0.218
None
improvementIn the pooled hypericum arms (n=147), early improvement in somatic-gastrointestinal (p<0.001, r2=0.262) and hypochondriasis (p=0.004, r2=0.218) items from baseline to week 1 significantly predicted re
Effect: improvement; somatic-GI: p<0.001, r2=0.262; hypochondriasis: p=0.004, r2=0.218
None
improvementIn the pooled hypericum arms (n=147), early improvement in somatic-gastrointestinal (p<0.001, r2=0.262) and hypochondriasis (p=0.004, r2=0.218) items from baseline to week 1 significantly predicted re
Effect: improvement; somatic-GI: p<0.001, r2=0.262; hypochondriasis: p=0.004, r2=0.218
None
improvementIn the pooled hypericum arms (n=147), early improvement in somatic-gastrointestinal (p<0.001, r2=0.262) and hypochondriasis (p=0.004, r2=0.218) items from baseline to week 1 significantly predicted re
Effect: improvement; somatic-GI: p<0.001, r2=0.262; hypochondriasis: p=0.004, r2=0.218
None
improvementIn the pooled hypericum arms (n=147), early improvement in somatic-gastrointestinal (p<0.001, r2=0.262) and hypochondriasis (p=0.004, r2=0.218) items from baseline to week 1 significantly predicted re
Effect: improvement; somatic-GI: p<0.001, r2=0.262; hypochondriasis: p=0.004, r2=0.218
None
improvementIn the pooled hypericum arms (n=147), early improvement in somatic-gastrointestinal (p<0.001, r2=0.262) and hypochondriasis (p=0.004, r2=0.218) items from baseline to week 1 significantly predicted re
Effect: improvement; somatic-GI: p<0.001, r2=0.262; hypochondriasis: p=0.004, r2=0.218
None
improvementIn the pooled hypericum arms (n=147), early improvement in somatic-gastrointestinal (p<0.001, r2=0.262) and hypochondriasis (p=0.004, r2=0.218) items from baseline to week 1 significantly predicted re
Effect: improvement; somatic-GI: p<0.001, r2=0.262; hypochondriasis: p=0.004, r2=0.218
None
improvementIn the pooled hypericum arms (n=147), early improvement in somatic-gastrointestinal (p<0.001, r2=0.262) and hypochondriasis (p=0.004, r2=0.218) items from baseline to week 1 significantly predicted re
Effect: improvement; somatic-GI: p<0.001, r2=0.262; hypochondriasis: p=0.004, r2=0.218
None
improvementIn the pooled hypericum arms (n=147), early improvement in somatic-gastrointestinal (p<0.001, r2=0.262) and hypochondriasis (p=0.004, r2=0.218) items from baseline to week 1 significantly predicted re
Effect: improvement; somatic-GI: p<0.001, r2=0.262; hypochondriasis: p=0.004, r2=0.218
None
improvementIn the pooled hypericum arms (n=147), early improvement in somatic-gastrointestinal (p<0.001, r2=0.262) and hypochondriasis (p=0.004, r2=0.218) items from baseline to week 1 significantly predicted re
Effect: improvement; somatic-GI: p<0.001, r2=0.262; hypochondriasis: p=0.004, r2=0.218
None
improvementIn the pooled hypericum arms (n=147), early improvement in somatic-gastrointestinal (p<0.001, r2=0.262) and hypochondriasis (p=0.004, r2=0.218) items from baseline to week 1 significantly predicted re
Effect: improvement; somatic-GI: p<0.001, r2=0.262; hypochondriasis: p=0.004, r2=0.218
None
improvementIn the pooled hypericum arms (n=147), early improvement in somatic-gastrointestinal (p<0.001, r2=0.262) and hypochondriasis (p=0.004, r2=0.218) items from baseline to week 1 significantly predicted re
Effect: improvement; somatic-GI: p<0.001, r2=0.262; hypochondriasis: p=0.004, r2=0.218
None
improvementIn the pooled hypericum arms (n=147), early improvement in somatic-gastrointestinal (p<0.001, r2=0.262) and hypochondriasis (p=0.004, r2=0.218) items from baseline to week 1 significantly predicted re
Effect: improvement; somatic-GI: p<0.001, r2=0.262; hypochondriasis: p=0.004, r2=0.218
None
improvementIn the pooled hypericum arms (n=147), early improvement in somatic-gastrointestinal (p<0.001, r2=0.262) and hypochondriasis (p=0.004, r2=0.218) items from baseline to week 1 significantly predicted re
Effect: improvement; somatic-GI: p<0.001, r2=0.262; hypochondriasis: p=0.004, r2=0.218
None
improvementIn the pooled hypericum arms (n=147), early improvement in somatic-gastrointestinal (p<0.001, r2=0.262) and hypochondriasis (p=0.004, r2=0.218) items from baseline to week 1 significantly predicted re
Effect: improvement; somatic-GI: p<0.001, r2=0.262; hypochondriasis: p=0.004, r2=0.218